Selective decontamination of the digestive tract: Impact on cytokine release and mucosal damage after hemorrhagic shock

Critical Care Medicine

Volumn 30, Issue 6, 2002, Pages 1327-1333

  Kahlke, Volker ^a   Fändrich, Fred ^a   Brötzmann, Kerstin ^a   Zabel, Peter ^a   Schröder, Jörg ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Antibiotics; Gut; Hemorrhagic shock; Interleukin 6; Macrophages; Mucosal damage; Selective decontamination of the digestive tract; Sepsis; Tumor necrosis factor

Indexed keywords

ANTIBIOTIC AGENT; CYTOKINE; INTERLEUKIN 6; MONOKINE; POLYMYXIN B; TOBRAMYCIN SULFATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL TRANSLOCATION; BLEEDING; CONTROLLED STUDY; CYTOKINE RELEASE; DIGESTIVE SYSTEM; GRAM NEGATIVE BACTERIUM; HEMORRHAGIC SHOCK; IMMUNE RESPONSE; MACROPHAGE; MALE; MESENTERY LYMPH NODE; MONONUCLEAR CELL; MUCUS GLAND; NONHUMAN; PORTAL VEIN BLOOD; PRIORITY JOURNAL; RAT; SEPSIS;

EID: 0036274821     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200206000-00030     Document Type: Article

References (30)

1. Multiple organ failure. Pathophysiology and potential future therapy
2. Selective gut decontamination in intensive care and surgical practice: Where are we?
3. Does selective decontamination of the digestive tract reduce mortality for severely ill patients?
4. Tumor necrosis factor-alpha hyporesponsiveness of rat intestinal mononuclear cells and whole portal venous blood after hemorrhagic shock
5. Hemorrhagic shock-induced bacterial translocation is reduced by xanthine oxidase inhibition or inactivation
6. Selective decontamination of the digestive tract prevents secondary infection of the abdominal cavity, and endotoxemia and mortality in sterile peritonitis in laboratory rats
7. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes
8. Production of hybridoma growth factor by human monocytes
9. Intestinal mucosal lesion in low-flow states. I. Morphological, hemodynamic and metabolic reappraisal
10. The gut as a cytokine-producing organ: Relationship to bacterial translocation
11. Effect of different regimens of gut decontamination on bacterial translocation and mortality in experimental acute pancreatitis
12. Effect of hemorrhagic shock on bacterial translocation, intestinal morphology, and intestinal permeability in conventional and antibiotic-decontaminated rats
13. Role of the gut in multiple organ failure: Bacterial translocation and permeability changes
14. Bacterial translocation occurs in humans after traumatic injury: Evidence using immunofluorescence
15. Hemorrhage and resuscitation: Immunological aspects
16. Gut decontamination reduces bowel ischemia-induced lung injury in rats
17. Comparison of cytokine levels in rats subjected to superior mesenteric artery occlusion or hemorrhagic shock
18. The relationship between gut-derived endotoxemia and tumor necrosis factor, neopterin: Experimental and clinical studies
19. Induction of human interleukin-1 production by polymyxin B
20. Pathogenesis and presentation of early pancreatic infection in experimental acute necrotizing pancreatitis
21. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis
22. A critical review of antibiotic prophylaxis in severe acute pancreatitis
23. Selective digestive tract decontamination and vancomycin-resistant enterococcus isolation in the surgical intensive care unit
24. Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tract: A randomized, double blind, placebo-controlled study
25. Randomized, controlled trial of selective decontamination in 600 mechanically ventilated patients in multidisciplinary intensive care unit
26. Selective decontamination of the digestive tract in surgical patients. I. A systematic review of the evidence
27. The prevention of anastomotic leakage after total gastrectomy with decontamination I. A prospective, randomized double-blind, placebo-controlled multicenter trial
28. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease
29. The complex pattern of cytokines in serum from patients with meningococcal septic shock